<DOC>
	<DOCNO>NCT00772499</DOCNO>
	<brief_summary>The purpose study compare patient primary hypertension , non-blood pressure lower effect one-year therapy olmesartan medoxomil vs. atenolol change vascular structure function .</brief_summary>
	<brief_title>Vascular Improvement With Olmesartan Medoxomil Study</brief_title>
	<detailed_description />
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Hydralazine</mesh_term>
	<criteria>Male female 1875 year age Mean seat diastolic BP 90109 mean seat systolic BP 140179 Secondary hypertension Renal disease Diabetes mellitus Serum creatinine &gt; 3.0 mg/dL Hemoglobin &lt; 10 mg/dL ( male ) &lt; 9mg/dL ( female ) WBC count &lt; 2000 cells/mL Platelet count &lt; 100,000 cells/mL Either ALT &amp; AST &gt; 2.5 x upper limit normal BMI &gt; 35 kg/m2 TIA cerebrovascular attack within 3 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>